Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SELNET clinical practice guidelines for bone sarcoma.
Blay JY, Palmerini E, Bollard J, Aguiar S, Angel M, Araya B, Badilla R, Bernabeu D, Campos F, Chs CS, Carvajal Montoya A, Casavilca-Zambrano S, Castro-Oliden 5th, Chacón M, Clara-Altamirano MA, Collini P, Correa Genoroso R, Costa FD, Cuellar M, Dei Tos AP, Dominguez Malagon HR, Donati DM, Dufresne A, Eriksson M, Farias-Loza M, Frezza AM, Frisoni T, Garcia-Ortega DY, Gerderblom H, Gouin F, Gómez-Mateo MC, Gronchi A, Haro J, Hindi N, Huanca L, Jimenez N, Karanian M, Kasper B, Lopes A, Lopes David BB, Lopez-Pousa A, Lutter G, Maki RG, Martinez-Said H, Martinez-Tlahuel JL, Mello CA, Morales Pérez JM, Moura DS, Nakagawa SA, Nascimento AG, Ortiz-Cruz EJ, Patel S, Pfluger Y, Provenzano S, Righi A, Rodriguez A, Santos TG, Scotlandi K, Mlg S, Soulé T, Stacchiotti S, Valverde CM, Waisberg F, Zamora Estrada E, Martin-Broto J. Blay JY, et al. Among authors: aguiar s. Crit Rev Oncol Hematol. 2022 Jun;174:103685. doi: 10.1016/j.critrevonc.2022.103685. Epub 2022 Apr 21. Crit Rev Oncol Hematol. 2022. PMID: 35460913 Free article. Review.
SELNET clinical practice guidelines for soft tissue sarcoma and GIST.
Blay JY, Hindi N, Bollard J, Aguiar S Jr, Angel M, Araya B, Badilla R, Bernabeu D, Campos F, Caro-Sánchez CHS, Carvajal B, Carvajal Montoya A, Casavilca-Zambrano S, Castro-Oliden V, Chacón M, Clara M, Collini P, Correa Genoroso R, Costa FD, Cuellar M, Dei Tos AP, Dominguez Malagon HR, Donati D, Dufresne A, Eriksson M, Farias-Loza M, Fernandez P, Frezza AM, Frisoni T, Garcia-Ortega DY, Gelderblom H, Gouin F, Gómez-Mateo MC, Gronchi A, Haro J, Huanca L, Jimenez N, Karanian M, Kasper B, Lopes David BB, Lopez-Pousa A, Lutter G, Martinez-Said H, Martinez-Tlahuel J, Mello CA, Morales Pérez JM, Moura David S, Nascimento AG, Ortiz-Cruz EJ, Palmerini E, Patel S, Pfluger Y, Provenzano S, Righi A, Rodriguez A, Salas R, Santos TTG, Scotlandi K, Soule T, Stacchiotti S, Valverde C, Waisberg F, Zamora Estrada E, Martin-Broto J. Blay JY, et al. Among authors: aguiar s jr. Cancer Treat Rev. 2022 Jan;102:102312. doi: 10.1016/j.ctrv.2021.102312. Epub 2021 Nov 14. Cancer Treat Rev. 2022. PMID: 34798363 Free article. Review. No abstract available.
Corrigendum to "SELNET clinical practice guidelines for bone sarcoma" Critical reviews in oncology/hematology, vol. 174 (2022), 1-10.
Blay JY, Palmerini E, Bollard J, Aguiar S, Angel M, Araya B, Badilla R, Bernabeu D, Campos F, Chs CS, Carvajal Montoya A, Casavilca-Zambrano S, Castro-Oliden 5th, Chacón M, Clara-Altamirano MA, Collini P, Correa Genoroso R, Costa FD, Cuellar M, Dei Tos AP, Dominguez Malagon HR, Donati DM, Dufresne A, Eriksson M, Farias-Loza M, Frezza AM, Frisoni T, Garcia-Ortega DY, Gerderblom H, Gouin F, Gómez-Mateo MC, Gronchi A, Haro J, Hindi N, Huanca L, Jimenez N, Karanian M, Kasper B, Lopes A, Lopes David BB, Lopez-Pousa A, Lutter G, Maki RG, Martinez-Said H, Martinez-Tlahuel JL, Mello CA, Morales Pérez JM, Moura DS, Nakagawa SA, Nascimento AG, Ortiz-Cruz EJ, Patel S, Pfluger Y, Provenzano S, Righi A, Rodriguez A, Santos TG, Scotlandi K, Mlg S, Soulé T, Stacchiotti S, Valverde CM, Waisberg F, Zamora Estrada E, Martin-Broto J. Blay JY, et al. Among authors: aguiar s. Crit Rev Oncol Hematol. 2022 Dec;180:103827. doi: 10.1016/j.critrevonc.2022.103827. Epub 2022 Oct 8. Crit Rev Oncol Hematol. 2022. PMID: 36220678 Free article. No abstract available.
Impact of COVID-19 in pediatric oncology care in Latin America during the first year of the pandemic.
Villanueva G, Sampor C, Palma J, Villarroel M, Valencia D, Lombardi MG, Garcia WG, Caceres EL, Sobrero V, Garcia L, Cabrera V, Maza I, Velasquez T, Ugaz C, Vasquez JM, Coronado RD, Gonzalez N, Aguiar S, Dabezies A, Moreno F, Sardinas S, Gamboa Y, Maradiegue E, Fu L, Gassant P, Moreno K, Gonzales O, Schelotto M, Luna-Fineman S, Antoneli CG, Fuentes-Alabi S, Luciani S, Cappellano A, Chantada G, Vasquez L. Villanueva G, et al. Among authors: aguiar s. Pediatr Blood Cancer. 2022 Oct;69(10):e29748. doi: 10.1002/pbc.29748. Epub 2022 May 20. Pediatr Blood Cancer. 2022. PMID: 35593012 Free PMC article.
Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high-grade, operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment.
Senerchia AA, Macedo CR, Ferman S, Scopinaro M, Cacciavillano W, Boldrini E, Lins de Moraes VL, Rey G, de Oliveira CT, Castillo L, Almeida MT, Borsato ML, Lima E, Lustosa D, Barreto JH, El-Jaick T, Aguiar S, Brunetto A, Greggiani L, Cogo-Moreira H, Atallah A, Petrilli AS. Senerchia AA, et al. Among authors: aguiar s. Cancer. 2017 May 15;123(6):1003-1010. doi: 10.1002/cncr.30411. Epub 2016 Nov 7. Cancer. 2017. PMID: 28263383 Free article. Clinical Trial.
Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group--protocol ALL-99.
Brandalise SR, Pinheiro VR, Aguiar SS, Matsuda EI, Otubo R, Yunes JA, Pereira WV, Carvalho EG, Cristofani LM, Souza MS, Lee ML, Dobbin JA, Pombo-de-Oliveira MS, Lopes LF, Melnikoff KN, Brunetto AL, Tone LG, Scrideli CA, Morais VL, Viana MB. Brandalise SR, et al. Among authors: aguiar ss. J Clin Oncol. 2010 Apr 10;28(11):1911-8. doi: 10.1200/JCO.2009.25.6115. Epub 2010 Mar 8. J Clin Oncol. 2010. PMID: 20212252 Clinical Trial.
Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.
Mastellaro MJ, Seidinger AL, Kang G, Abrahão R, Miranda ECM, Pounds SB, Cardinalli IA, Aguiar SS, Figueiredo BC, Rodriguez-Galindo C, Brandalise SR, Yunes JA, Barros-Filho AA, Ribeiro RC. Mastellaro MJ, et al. Among authors: aguiar ss. Cancer. 2017 Aug 15;123(16):3150-3158. doi: 10.1002/cncr.30703. Epub 2017 Apr 7. Cancer. 2017. PMID: 28387921 Free PMC article.
Adrenocortical tumors associated with the TP53 p.R337H germline mutation can be identified during child-care consultations.
Mastellaro MJ, Ribeiro RC, Oliveira-Filho AG, Seidinger AL, Cardinalli IA, Miranda ECM, Aguiar SS, Brandalise SR, Yunes JA, Barros-Filho AA. Mastellaro MJ, et al. Among authors: aguiar ss. J Pediatr (Rio J). 2018 Jul-Aug;94(4):432-439. doi: 10.1016/j.jped.2017.06.009. Epub 2017 Aug 30. J Pediatr (Rio J). 2018. PMID: 28864397 Free article.
Occurrence of Neuroblastoma among TP53 p.R337H Carriers.
Seidinger AL, Fortes FP, Mastellaro MJ, Cardinalli IA, Zambaldi LG, Aguiar SS, Yunes JA. Seidinger AL, et al. PLoS One. 2015 Oct 9;10(10):e0140356. doi: 10.1371/journal.pone.0140356. eCollection 2015. PLoS One. 2015. PMID: 26452166 Free PMC article.
296 results